# persona_off · bixbench · bix-43-q1

[All trial-1 traces](../../README.md)

- Trial: **1**; endpoint: **repaired**; attempt: **2**.
- Native status: **missing_submission**; normalized native score: **0/100**.
- Recorded protocol: `researcher-review-v2`.
- Actor, simulator, and judge: **GPT-6 Astra, low reasoning**.
- Scope: chronological shared messages and handoff fields. Private tool logs, system prompts, evaluator references, and raw API requests are not included.
- A repaired endpoint belongs to the same trial; it is not an independent repeat. Zero scores and missing scientific submissions are retained.

## Shared conversation

### Event 1 — Simulator

**Message**

````text
Inspect the supplied input files and any repository documentation or existing analysis code only; do not execute the full analysis yet. Report matrix dimensions and identifier format, count-data validity, sample-layout group labels and replicate structure, how CBD/cisplatin and DMSO samples map to count columns, and coverage/ambiguities in the ENSG-to-gene-name mapping. Propose a reproducible differential-expression and gseapy enrichment approach using GO_Biological_Process_2021, identifying any documented settings versus assumptions, particularly filtering, comparison design, significance and effect-size thresholds, direction pooling, enrichment background, and multiple-testing adjustment. Note available tooling/library access and consequential uncertainties. The eventual deliverable must name the cellular process with the lowest adjusted enrichment p-value and retain an executed analysis script or notebook.
````

**Interaction**

````text
initial_request
````

**Phase**

````text
initial_inspection
````

**Action**

````text
continue
````

**Approve Approach**

````text
false
````

**Evidence**

````text
Only input filenames and header schemas have been supplied. Treatment labels, data quality, and analysis settings have not yet been inspected.
````

**Objectives Open**

````text
[
  "Inspect inputs and identify the CBD/cisplatin versus DMSO comparison.",
  "Review and authorize an explicit differential-expression and enrichment approach.",
  "Execute the agreed analysis and report the lowest-adjusted-p-value GO biological process with retained analysis evidence."
]
````

### Event 8 — Actor

**Answer**

````text
Inspection only is complete; no differential expression or enrichment has been executed.

**Inputs and sample mapping**
- The repository contains only task.json and the three supplied data files: no README, notebook, analysis code, or documented statistical settings.
- Counts: 63,677 genes × 30 samples, with unique, unversioned human-style IDs matching `ENSG` plus 11 digits. All counts are finite, nonnegative integers, with no missing values; range 0–906,308. There are 27,954 all-zero genes across all samples.
- Layout has 10 groups of three samples each. Prefixes 1–10 respectively identify: Untreated; Serum_starvation; DMSO; DMSO_Serum_starvation; Cisplatin_IC50; Cisplatin_IC50_Serum_starvation_16h; CBD_IC50; CBD_IC50_Serum_starvation_16h; Cisplatin_IC50_CBD_IC50; Cisplatin_IC50_CBD_IC50_Serum_starvation_16h. Sample suffixes are 1–3. Biological versus technical replication is not documented; no batch or pairing metadata is supplied.
- Replacing hyphens in layout SampleID with underscores gives an exact ordered match to all 30 count columns. Primary comparison: combination `9_1,9_2,9_3` versus DMSO `3_1,3_2,3_3`. The serum-starved combination is a separate group and should not be pooled into this contrast.
- Library sizes in DMSO are 8,200,746 / 29,317,321 / 39,547,354; combination sizes are 18,549,847 / 10,540,022 / 34,834,875. Normalization and sample QC are important; low depth alone would not justify sample exclusion.

**Mapping coverage**
- Mapping has 86,369 unique ENSG keys, 79,122 distinct gene names, no missing fields, no duplicate rows, and no ENSG mapping to multiple names.
- 53,636 of the 63,677 count IDs map to names (~84.2%); 10,041 do not. Mapped count IDs represent 50,746 unique names.
- Many-to-one mapping exists: 3,369 names have multiple ENSG IDs in the whole mapping; 496 names have multiple IDs among count genes. Keep ENSG-level DE tests, then deduplicate mapped symbols for enrichment; do not duplicate gene-list entries or silently merge raw-count rows. Report post-filter and DE-list mapping attrition.

**Proposed reproducible approach (requires approval and tooling access)**
1. Write and retain an executable analysis script, version information, QC summary, full DE table, selected symbol list, cached library, and enrichment table.
2. Primary DE analysis on the six selected samples only, treating the three samples per condition as independent replicates. Prefilter to count ≥10 in ≥3 of six samples (16,353 genes pass this candidate filter; 34,137 genes are all-zero within these six samples). Fit PyDESeq2 negative-binomial models with median-ratio size factors, design `~ Group`, and explicit combination-versus-DMSO contrast. Use standard dispersion estimation, Wald tests, Cook's outlier handling/refitting and independent filtering; record exact installed-version settings. Set DE alpha=0.05; apply Benjamini–Hochberg adjustment across genes under the package's independent-filtering convention.
3. Primary list: finite gene-level adjusted p-value <0.05 and |log2 fold change| >1, pooling up- and downregulated genes. Map using the supplied TSV, drop unmapped IDs, and deduplicate names. No shrinkage is proposed for this threshold. These choices, including prefilter and effect threshold, are assumptions, not documented methods.
4. Use **gseapy** overrepresentation enrichment with **GO_Biological_Process_2021**, downloaded and cached as human term-to-symbol sets. Proposed primary background: unique mapped symbols among DE genes eligible for selection (finite adjusted p-values), restricted to the library's annotated symbols; intersect the query consistently. Pass an explicit background to local `gseapy.enrichr` rather than silently using the remote service's default genome background. This assay-specific background is a proposed choice, not a supplied requirement. Record library content/hash, effective universe size, overlaps, and package version. Use gseapy's BH-adjusted enrichment p-values within this one library; return the term with the smallest adjusted p-value, reporting ties if present. Do not select by combined score or nominal p-value.
5. Because the expected enrichment convention is undocumented, include labeled sensitivity checks for no effect-size cutoff and for standard Enrichr default background, if service access permits. Direction-specific enrichment can be a diagnostic, not a replacement for the pooled primary answer. Avoid choosing settings after observing the preferred term. If these choices yield different top processes, report that limitation for researcher review.

**Documented versus assumed**
Only the treatment/control comparison, use of gseapy, and GO_Biological_Process_2021 library are specified. DE method, six-sample versus all-group fitting, filtering, DE alpha, fold-change threshold, pooling directions, enrichment background, and multiple-testing procedure are not documented. The choices above are an explicit proposed primary workflow, not a reconstruction of existing code.

**Tooling constraint**
Python has pandas, NumPy, SciPy and statsmodels. PyDESeq2, anndata and gseapy are absent; Rscript was not found on PATH; this Python lacks pip. HTTPS probes to both PyPI and Enrichr failed DNS resolution. There is no local GO library in the repository. Thus the requested workflow currently needs package installation/access and a GO_Biological_Process_2021 library copy (or restored networking); a substitute hand-coded enrichment test would not satisfy the explicit gseapy requirement. Please approve or revise the proposed primary choices and provide a route to the required packages/library. The eventual deliverable will name the lowest-adjusted-p-value cellular process and retain an executed nonempty script, but neither result nor execution is claimed at this inspection stage.
````

**Stage**

````text
plan
````

**Evidence**

````text
Loaded all three supplied tables for schema/validity checks only. Counts shape=(63677,30), integer/nonnegative/finite checks all pass, IDs unique. Layout transformed SampleID list equals count columns exactly. Mapping shape=(86369,2); matched count IDs=53636; unmatched=10041; count-associated symbols=50746. Candidate six-sample count filter retains 16353 genes. Repository listing found no analysis code/documentation beyond task.json. importlib checks found gseapy/pydeseq2/anndata absent; command -v Rscript gave no path; python -m pip failed; curl probes failed DNS.
````

**Assumptions**

````text
[
  "Group 9, without serum starvation, is the requested CBD/cisplatin combination.",
  "Three sample suffixes denote independent replicates; pairing and biological origin are undocumented.",
  "Primary prefilter, DESeq2-style model, BH thresholds, pooled directions and assay-specific enrichment background are proposed choices rather than documented settings."
]
````

**Uncertainties**

````text
[
  "Required gseapy/PyDESeq2 packages and GO library are not currently accessible through inspected runtime/network.",
  "Unknown original DE/enrichment conventions could change the top term.",
  "Incomplete gene-name mapping and many-to-one symbols can change effective enrichment coverage.",
  "No batch, replicate-type, organism provenance or sample-quality metadata beyond sample labels is available."
]
````

### Event 9 — Simulator

**Message**

````text
Proceed with the proposed six-sample DE and pooled enrichment workflow, retaining the documented-versus-assumed distinction. One refinement: define the assay-specific primary universe from all prefiltered, mapped, library-annotated genes tested in DE, rather than restricting it to finite adjusted p-values, since independent filtering is data-dependent. Keep the proposed DE padj<0.05 and absolute log2 fold change>1 thresholds and the labeled no-effect-cutoff and default-Enrichr-background sensitivity checks where feasible. Rank strictly by adjusted enrichment p-value and report ties or sensitivity-dependent winners. First investigate available runner tooling, alternate installed environments, package caches, and legitimate network/library access to resolve the reported dependency block; I cannot supply packages or a library from the information available here. Do not replace gseapy or the specified library with a hand-coded approximation or invent results. If access is resolved, execute and retain the script, package/library provenance, sample QC, DE selection/mapping counts, and top enrichment rows with adjusted p-values and overlaps. If it remains blocked, report the specific attempts and retain a reproducible script clearly marked unexecuted; do not claim the requested analysis was executed. Return the concise answer when supported, payload.executed_analysis truthful to actual execution, and artifacts.analysis pointing to the retained script or notebook.
````

**Interaction**

````text
next_task
````

**Phase**

````text
approach_review
````

**Action**

````text
continue
````

**Approve Approach**

````text
true
````

**Evidence**

````text
Inspection identifies the non-serum-starved combination and DMSO samples unambiguously, validates raw counts, and documents mapping attrition. The proposed statistical settings are reasonable explicit assumptions, not recovered source methods. Missing dependencies and failed DNS remain an execution feasibility issue; no enrichment result is yet available.
````

**Objectives Open**

````text
[
  "Resolve access to gseapy, DE tooling, and GO_Biological_Process_2021 or document the remaining block.",
  "Execute the agreed contrast and enrichment, with diagnostics and labeled sensitivity checks.",
  "Identify the lowest-adjusted-p-value cellular process and retain the analysis artifact with truthful execution status."
]
````

### Event 20 — Actor

**Answer**

````text
The cellular process with the lowest adjusted enrichment p-value cannot be determined in this environment: the required DE/enrichment workflow remains blocked, and no enrichment results were invented.

Retained `analysis.py` implements the approved six-sample design, prefilter, DE padj<0.05 and |log2FC|>1 selection, pooled directions, and gseapy GO_Biological_Process_2021 enrichment. Its primary universe uses all prefiltered, mapped, library-annotated DE-tested genes, including genes whose adjusted p-values are missing after independent filtering, as requested. It also includes no-effect-cutoff and, where accessible, remote default-Enrichr-background sensitivities; winner selection uses adjusted enrichment p-values strictly and retains exact ties. Documented requirements are distinguished from assumed settings in the script.

**Access investigation:** The actor environment lacks gseapy, PyDESeq2, anndata and pip. An alternate system Python and pip were found, but neither required analysis package is installed there. System pip installation failed because its configured TLS CA bundle is absent. Independently, DNS resolution failed for PyPI, its file host and Enrichr; `/etc/resolv.conf` is absent. No configured proxy/access route was found. Searches of available home, mounted environment, and system library paths found no relevant packages or GMT library; pip reported no cached wheels. The sole wheel discovered was ensurepip's bundled pip, which cannot supply the missing statistical packages or GO library. Rscript, conda and uv were not found on PATH.

The script was syntax-parsed only, **not executed**. It is therefore an incomplete deliverable, not executed BixBench evidence. Once legitimate dependency and library access are restored, it is designed to retain package/library provenance, sample QC, DE results, mapping/selection counts, full enrichment tables and minimum-adjusted-p-value terms. Package/API behavior remains unvalidated at runtime.
````

**Stage**

````text
result
````

**Evidence**

````text
System pip 24.0 under Python 3.12.3 was located; attempted installation emitted: 'Could not find a suitable TLS CA certificate bundle, invalid path: /etc/ssl/certs/ca-certificates.crt'. socket.getaddrinfo for pypi.org, files.pythonhosted.org, maayanlab.cloud and pypi.python.org returned temporary failure in name resolution; curl probes also failed resolution. Local package/library searches found only pip-25.0.1's ensurepip wheel, and pip cache list reported no cached wheels. analysis.py is nonempty and passed ast.parse, explicitly without execution. Previously inspected counts are 63677×30; requested six-sample prefilter retains 16353 genes, but no DE or enrichment estimates exist.
````

**Assumptions**

````text
[
  "Approved statistical choices are encoded but not numerically executed.",
  "Network/package and exact GO-library access must be restored before a supported answer is possible."
]
````

**Uncertainties**

````text
[
  "No top process, adjusted enrichment p-value, overlap or sensitivity-dependent winner can be reported without execution.",
  "The retained script has syntax validation only, not runtime/API validation; package versions will be captured on actual execution."
]
````

### Event 21 — Simulator

**Message**

````text
Conclude with the reported inability to determine the cellular process, explicitly attributing it to unavailable dependencies and GO library access. Preserve payload.executed_analysis=false and artifacts.analysis="analysis.py"; describe the script as syntax-checked but unexecuted, not execution evidence. Do not name a process or imply that enrichment was completed. The scientific question remains unanswered, but the documented environment block provides no supported route to further analysis in this session.
````

**Interaction**

````text
conclude
````

**Phase**

````text
result_review
````

**Action**

````text
stop
````

**Approve Approach**

````text
false
````

**Evidence**

````text
The agent reports unsuccessful dependency installation, DNS and TLS failures, no cached required packages or GO library, and only syntax validation of the retained script. No DE or enrichment results exist. This matches the authorized blocked-workflow fallback, although it does not fulfill the original scientific objective or executed-analysis requirement.
````

**Objectives Open**

````text
[
  "Execute the approved DE and gseapy GO_Biological_Process_2021 enrichment workflow when dependencies and library access are available.",
  "Identify the process with the minimum adjusted enrichment p-value and retain executed analysis evidence."
]
````

### Event 22 — Controller termination

**Reason**

````text
No complete, researcher-reviewed final candidate at termination
````

## Provenance

````text
{
  "source_run": "runs/openai-astra-top2-first-pass",
  "repair_run": "runs/repair-1-openai-astra-top2-first-pass",
  "event_log": "runs/repair-1-openai-astra-top2-first-pass/episodes/bixbench_bix-43-q1-5761e7fff266/persona_off/attempt-2/output/bixbench_bix-43-q1-5761e7fff266/controller/events.jsonl",
  "event_log_sha256": "05fa0dbe8b9e8452a0282ac7178ba4f23ea35e836decf59365f7f8c31982cbf4",
  "models": {
    "actor": {
      "model": "gpt-6-astra",
      "provider": "openai",
      "reasoning_effort": "low"
    },
    "researcher": {
      "model": "gpt-6-astra",
      "provider": "openai",
      "reasoning_effort": "low"
    },
    "judge": {
      "model": "gpt-6-astra",
      "provider": "openai",
      "reasoning_effort": "low"
    }
  }
}
````
